[1] Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis. Retrieved May 28, 2024, from https://www.businesswire.com/news/home/20240528509212/en
[2] Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs. Retrieved May 28, 2024, from https://www.businesswire.com/news/home/20240527063643/en/Cartography-Announces-Strategic-Collaboration-with-Gilead-to-Develop-Oncology-Therapies-Against-Novel-Targets-and-Target-Pairs
[3] MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech. Retrieved May 28, 2024, from https://www.medilinkthera.com/news-details/35